Baxter, J.S.,
Johnson, N.,
Tomczyk, K,
Gillespie, A.,
Maguire, S.,
Brough, R.,
Fachal, L,
Michailidou, K.,
Bolla, M.K.,
Wang, Q.,
Dennis, J.,
Ahearn, T.U.,
Bermisheva, M. (2021) risk loci at 2q35. A recent fine-scale mapping analysis to refine these associations resulted in 1
Mukhammadiyeva, G.F.,
Shaikhlislamova, E.R.,
Karimov, D.D.,
Karimov, D.O.,
Repina, E.F.,
Yakupova, T.G.,
Kudoyarov, E.R. (2024) 16944), MMP-1 (rs1799750) and SOD2 (rs4880) gene polymorphisms with the
risk of developing vibration
-based biochemistry training, and methodical approaches to
assessing the devel-opment of competences in students.
Urakov, Aleksandr,
Urakova, Natalya,
Samorodov, Aleksandr,
Shabanov, Petr,
Yagudin, Ilnur,
Stolyarenko, Anastasia,
Suntsova, Darya,
Muhutdinov, Nikita (2024) complications. As the current standard for drug quality control does not include an
assessment of the local
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) risk of developing disease outcomes from the general population. Clear cell renal cell carcinoma (cc